β-D-Glcp-(1→3)-β-D-Glcp-(1→4)-β-D-Glcp

Metabolite details

Identifier

ODDPRQJTYDIWJU-YTJFHSSISA-N

InChI Key

ODDPRQJTYDIWJU-YTJFHSSISA-N

IUPAC name

Glc(b1-3)Glc(b1-4)b-Glc

Preferred name

β-D-Glcp-(1→3)-β-D-Glcp-(1→4)-β-D-Glcp

INN name

—

Synonym

(2S,3R,4S,5S,6R)-2-[(2R,3R,4S,5R,6S)-3,5-Dihydroxy-2-(hydroxymethyl)-6-[(2R,3S,4R,5R,6R)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-4-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol

ChEBI

CHEBI:146922

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Hfq Regulates Efflux Pump Expression and Purine Metabolic Pathway to Increase the Trimethoprim Resistance in Aeromonas veronii
• Metabolic Dynamics of In Vitro CD8+ T Cell Activation.

Observed in differential profiles

• Wild_type_vs_hfq
• G3_Experimental_Sample_0h_vs_G11_Experimental_Sample_96h